天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

methylglucopyranosiduronic acid

methylglucopyranosiduronic acid Struktur
4356-84-7
CAS-Nr.
4356-84-7
Englisch Name:
methylglucopyranosiduronic acid
Synonyma:
Methyl β-glucuronide;methyl beta-D-glucuronoside;methylglucopyranosiduronic acid;methyl β-D-glucopyranosiduronic acid;β-D-Glucopyranosiduronic acid, methyl;(2S,3S,4S,5R,6R)-3,4,5-Trihydroxy-6-methoxytetrahydro-2H-pyran-2-carboxylic acid
CBNumber:
CB71369466
Summenformel:
C7H12O7
Molgewicht:
208.17
MOL-Datei:
4356-84-7.mol

methylglucopyranosiduronic acid Eigenschaften

Sicherheit

methylglucopyranosiduronic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

Definition

ChEBI: A derivative of beta-D-glucuronic acid in which a methyl group is present at the anomeric position.

methylglucopyranosiduronic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


methylglucopyranosiduronic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
BOC Sciences
+1-631-485-4226
inquiry@bocsci.com United States 19553 58
Shanghai Haohong Pharmaceutical Co., Ltd. 4008210725 4008210725
malulu@leyan.com China 54987 58
Shanghai Sunway Pharmaceutical Technology Co.,Ltd. 021-51816796-820 13611835272
sales2@sunwaypharm.com China 44458 58
QUALITY CONTROL SOLUTIONS LTD. 0755-66853366; 13670046396
ORDERS@QCSRM.COM China 24342 58
Beijing Qinling Pharmaceutical Co., Ltd. 010-61241352 18901327973
834537306@qq.com China 4843 58
Guangzhou Max Pharmaceutical Research Co., Ltd. 020-18027400382 18027400382
sale@gzmaxscience.com China 189 58
Carbosynth --
sales@carbosynth.com United Kingdom 6005 58

  • methylglucopyranosiduronic acid
  • methyl beta-D-glucuronoside
  • (2S,3S,4S,5R,6R)-3,4,5-Trihydroxy-6-methoxytetrahydro-2H-pyran-2-carboxylic acid
  • β-D-Glucopyranosiduronic acid, methyl
  • methyl β-D-glucopyranosiduronic acid
  • Methyl β-glucuronide
  • 4356-84-7
Copyright 2019 ? ChemicalBook. All rights reserved